In a series of experiments on mice, a line of human fetal neural stem cells, HK532-IGF-1, reversibly immortalized with c-Myc and modified to increase the expression of IGF-1, was evaluated for the treatment of Alzheimer’s disease. Here, IGF1 is linked to Alzheimer disease.